Viking Therapeutics Free Cash Flow (Quarterly) Analysis

Viking Therapeutics Inc (VKTX)

76.43 -3.15 (-3.96%) USD | NASDAQ | May 01, 16:00

77.20 +0.77 (+1.01%) After-Hours: 04:28

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2013. Upgrade now.

Date	Value
March 31, 2024	-6.134M
December 31, 2023	-17.64M
September 30, 2023	-19.66M
June 30, 2023	-11.44M
March 31, 2023	-24.64M
December 31, 2022	-10.93M
September 30, 2022	-13.50M
June 30, 2022	-13.44M
March 31, 2022	-10.53M
December 31, 2021	-12.35M
September 30, 2021	-10.93M
June 30, 2021	-13.43M
March 31, 2021	-10.88M
December 31, 2020	-5.486M
September 30, 2020	-5.323M
June 30, 2020	-6.666M
March 31, 2020	-4.302M
December 31, 2019	-11.74M
September 30, 2019	-3.398M
June 30, 2019	-6.459M
March 31, 2019	-3.152M
December 31, 2018	-2.679M

Date	Value
September 30, 2018	-5.503M
June 30, 2018	-5.27M
March 31, 2018	-5.303M
December 31, 2017	-3.947M
September 30, 2017	-3.329M
June 30, 2017	-4.202M
March 31, 2017	-3.28M
December 31, 2016	-2.465M
September 30, 2016	-2.654M
June 30, 2016	-3.227M
March 31, 2016	-2.725M
December 31, 2015	-3.299M
September 30, 2015	-3.400M
June 30, 2015	-1.621M
March 31, 2015	-0.4109M
December 31, 2014	-0.441M
September 30, 2014	-0.6098M
June 30, 2014	-0.4399M
March 31, 2014	-0.1008M
June 30, 2013	-0.0099M
March 31, 2013	0.00

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-24.64M

Minimum

Mar 2023

-3.398M

Maximum

Sep 2019

-10.94M

Average

-10.93M

Median

Sep 2021

Free Cash Flow (Quarterly) Benchmarks